Molecular Diagnostics Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease Area, Technology, Product & Services, End User, and Geography

Description

List of Tables

The molecular diagnostics market size is expected to reach US$ 45,875.65 million by 2030 from US$ 18,173.87 million in 2022; it is estimated to register a CAGR of 12.3% from 2022 to 2030. The report highlights trends prevailing in the market and the factors driving and hindering the molecular diagnostics market growth. The growth of the market is attributed to the development of new products and increase in demand for point-of-care testing and surging prevalence of associated diseases. However, limitations associated with molecular testing hinders the market growth.

Molecular Diagnostics in Personalized Medicine for Molecular Diagnostics Market Growth in the Upcoming Years

With progress in high-throughput techniques, genome research has become more convenient and cost effective. Molecular diagnostics is becoming increasingly indispensable in clinical laboratories as these kits and tests provide rapid detection results as opposed to the conventional tests, which also involved culturing microbes in laboratory conditions in some cases. Using precision medicine, medical treatments and interventions are tailored to each patient based on their unique genetic makeup, lifestyle, and environment. Molecular diagnostics plays an important role in this approach, as it enables the identification of specific biomarkers, genetic mutations, and gene expression patterns that impact decision-making related to the treatment of patients. Drug development has become increasingly dependent on molecular diagnostics. A wide range of molecular imaging techniques are used in screening, detecting, diagnosing, treating, and assessing heterogeneity; making progression plans; examining molecular characteristics; and monitoring patient outcomes. In addition, molecular imaging can aid in the detection of tiny tumors and assessment of their activities, contributing significantly to the development and expansion of personalized medicine, research, clinical trials, and medical practice in oncology. A high-throughput genotyping platform can be used to detect genetic aberrations in clinical samples, and next-generation sequencing can be used to identify all types of cancer-causing changes. The introduction of these techniques into clinical practice would enable the identification of molecular targets in each patient, along with facilitating the tracking of the molecular progression of diseases. With these approaches, cancer patients will be able to receive personalized medicine. Thus, with technology ever evolving, the market for molecular diagnostics seems to have a bright future.

Limitations Associated with Molecular Testing Hampers the Market Growth

The outcomes of molecular testing depend on sampling and testing processes, technicians' skill sets, etc., which may lead to variations in test results. Further, some test procedures take longer for producing results. Several times, test kits may show false positive or negative results. Thus, uncertainties associated with molecular tests hamper their adoption, especially in diagnostics and treatment of life-threatening diseases. The limited awareness of point-of-care tests, particularly in developing and underdeveloped countries, also hinders the market growth. In addition, the cost of molecular testing for indications such as cancer and viral infections, and the shortage of supplies are hampering the molecular diagnostics market.

Molecular Diagnostics Market, By Disease Area Insights

Based on disease area, the molecular diagnostics market is segmented into oncology, infectious disease, genetic testing, cardiac diseases, immune system disorders, and others.

The infectious disease segment held the largest market share in 2022. However, oncology segment is anticipated to register the highest CAGR of 12.6% during the forecast period. Oncology molecular diagnostics are tests that expose inherited material, proteins, associated molecules and assess metabolic functions, drug metabolism, and disease induction grounded on DNA, RNA, and proteins that deliver oncological information. As stated by World Health Organization (WHO), cancer reckoned for roughly 10 million demises in 2020. Furthermore, as per the 2021 statistics by the American Cancer Society, by 2040, the global burden of carcinoma is anticipated to raise to 27.5 million fresh cases and 16.3 million cancer deceases. Such like high figures denote that the evaluated rising frequency of cancer is chipping into the accelerating requirement for primitive diagnosis and preventive cure. There are numerous methods to diagnose carcinoma comprehending PCR, INAAT, and NGS etc. Among all the conception of PCR (polymerase chain reaction) led to an enormous advancement in clinical DNA testing. PCR-based methodologies demand straightforward instrumentation and infrastructure, exploit only minute quantities of biological material and are extensively harmonious with clinical routine.

Although the cost of PCR is lofty, most accurate real-time PCR approach (with more than 99% accuracy) is the one substantially used in numerous developed countries including Korea, while developing countries substantially exploit the conventional PCR (more than 90% accuracy), which is affordable than real-time PCR. Because of the high prices of the other options, underdeveloped countries generally use Rapid PCR (60 - 70% accuracy). Within the field of oncology molecular diagnostics, NGS is another technology flaunting the loftiest rate of growth. Numerous companies are working intensely to make economic use of this technology. For instance, in April 2021, Illumina Inc. blazoned its partnership with Kartos Therapeutics to co-develop an NGS- Based TP53 Companion Diagnostic, which aided to reduce the costs associated with storing and managing of genomic data.

Molecular Diagnostics Market, By Technology-Based Insights

Based on technology, the molecular diagnostics market is segmented into polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing & Next-Generation sequencing, DNA microarrays, in-situ hybridization, and others. The PCR is further sub segmented into RT-PCR, qPCR, Multiplex PCR, and others. The PCR segment held the largest share of the market in 2022, and the same segment is anticipated to register the highest CAGR of 12.7% in the market during the forecast period. PCR is mainly used to make or amplify DNA by copying the nucleic acid strands. Thermal cyclers are employed to denature and anneal DNA strands during amplification, along with reagents such as enzymes, nucleotides, and buffers to build the novel DNA. This technique is widely used in various application such as functional analysis of genes, diagnosis of hereditary, DNA cloning, paternity testing, detection of infectious diseases, and forensic sciences. Polymerase chain reaction has been classified into traditional PCR, real-time PCR, and digital PCR. However, ongoing technological advances and surging demand amid the pandemic will continue to fuel the need for PCR tests in India as well as other Asia Pacific countries. Consistent prevalence of diseases like tuberculosis, Hepatitis, flu, and serious infections will foster PoC molecular diagnostic industry trends. Presently, the outbreak of novel COVID-19 pandemic would create lucrative growth aspects for the market as this approach is highly critical to detect virus in individuals who exhibit no symptoms of signs of disease. PCR's exquisite sensitivity, relative simplicity, and cost-effectiveness makes PCR stand apart from other nucleic acid amplification techniques, cementing it as a mainstay in molecular laboratories. PCR has become an indispensable tool for various clinical and diagnostic applications or examinations due to continuous research & development on PCR technologies. Therefore, it offers many opportunities for rapid point-of-care diagnostics for various infectious diseases. For instance, F. Hoffmann-La Roche Ltd is continuously working on the advancements of Digital PCR (dPCR) techniques. dPCR has extended its applications to the clinical field and has emerged as an important clinical tool. dPCR offers ultrasensitive and absolute nucleic acid quantification without reference standard. Thus, it offers a broader aspect for standardizing and comparing results between laboratories.During pandemic outbreak, one of the first mover startup, Mylab PathoDetect COVID-19 Qualitative PCR kit was among the first in the country to receive commercial approval from the Central Drugs Standard Control Organisation (CDSCO) last year. Following the approval, Mylab had partnered with biotech giant Serum Institute of India and local firm AP Globale. PCR is further sub-segmented into RT-PCR, qPCR, multiplex PCR and others. Molecular Diagnostics Market, By Purchase Mode-Based Insights.

Based on product & services, the molecular diagnostics market is segmented into assays & kits, instruments, and services & software. The assays and kits segment are held the largest share of the market in 2022, and it is anticipated to register the highest CAGR in the market during the forecast period. Molecular Diagnostics assays are among the widely used technique for analysis. Various types of assays such as rapid molecular assays, reverse transcription-polymerase chain reaction (RT-PCR), antigens, and others are used to identify and analyze various diseases such as influenza COVID 19, tuberculosis, and others. As part of product innovation and business strategies, the market players offer diagnostic kits for different test kits. The regional players are actively involved in business development related to the segment. For instance, In September 2021, Mylab Discovery Solutions acquired a majority stake in Sanskritech, developer of a platform Swayam a point of care testing system that can perform about 70 tests on the point. Moreover, in the COVID19 pandemic, various global market players offer their kits through their regional business divisions. Based on the above factors, the segment is expected to contribute remarkably during the forecast period.

Based on end user, the molecular diagnostics market is segmented into hospitals & clinics, diagnostic laboratories, research & academic institutions, and others. In 2022, the diagnostic laboratories segment held the largest share of the market. Moreover, the segment is also expected to witness growth in its demand at a fastest CAGR of 12.7% during 2022 to 2030, owing to the rise in the detection and diagnosis of various medical conditions across the regions. Diagnostic laboratories are the primary uses for molecular diagnostics products and services. It has well-established facilities as per the regulatory requirements. The laboratories use all possible molecular diagnostic products and services. The sample collected from the patients is analyzed and studied using different instruments, reagents, methods, and technologies. The labs provide services to hospitals, clinics, at-home care, and others. The increasing prevalence of chronic diseases, infectious diseases, outsourcing the molecular diagnostics activities by individual researchers are among the factors supporting the segment growth during the forecast period.

Molecular Diagnostics Market: Competitive Landscape and Key Developments

Abbott Laboratories, Agilent Technologies Inc., Thermo Fisher Scientific Inc, F. Hoffman-La Roche Ltd., Qiagen NV, bioMerieux SA, Illumnia Inc., Danaher, Siemens Healthineers AG, Novartis AG, and TBG Diagnostics Limited are among the leading companies operating in the molecular diagnostics market.

Market players are launching new products to the market. Below are few instances:

In January 2023, Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy Test. The agreement between Quest and Agilent will enable broad adoption for ctDx FIRST, a single-site premarket approved (ssPMA) test performed at the Resolution Bioscience CLIA laboratory in Washington.

In July 2023, Thermo Fisher launched new software for molecular diagnostics labs. This software helps in streamlining routine diagnostics testing for standardization and rapid time-to-results. It can enhance the potential of a lab to dynamically respond to quickly changing testing environments by connecting workflow steps within a single interface.

In October 2021, Agilent Technologies Inc. has announced its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) is now FDA approved as an aid in identifying patients with early breast cancer (EBC) at high risk of disease recurrence, for whom adjuvant treatment with Verzenio (abemaciclib) in combination with endocrine therapy.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the molecular diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Product Code: TIPRE00003124

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Molecular Diagnostics Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 South & Central America PEST Analysis
- 4.2.5 Middle East & Africa PEST Analysis

5. Molecular Diagnostics Market - Key Industry Dynamics

5.1 Key Market Drivers:
- 5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
- 5.1.2 Surging Prevalence of Associated Diseases
5.2 Market Restraints
- 5.2.1 Limitations Associated with Molecular Testing
5.3 Market Opportunities
- 5.3.1 Advancements in Molecular Diagnostics Technologies
5.4 Future Trends
- 5.4.1 Molecular Diagnostics in Personalized Medicine
5.5 Impact Analysis:

6. Molecular Diagnostics Market - Global Market Analysis

6.1 Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030

7. Global Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Disease Area

7.1 Overview
7.2 Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
7.3 Oncology
- 7.3.1 Overview
- 7.3.2 Oncology: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Infectious Disease
- 7.4.1 Overview
- 7.4.2 Infectious Disease: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Genetic Testing
- 7.5.1 Overview
- 7.5.2 Genetic Testing: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Cardiac Diseases
- 7.6.1 Overview
- 7.6.2 Cardiac Diseases: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Immune System Disorders
- 7.7.1 Overview
- 7.7.2 Immune System Disorders: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Technology

8.1 Overview
8.2 Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Polymerase Chain Reaction
- 8.3.1 Overview
- 8.3.2 PCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 RT-PCR
    - 8.3.2.1.1 Overview
- 8.3.3 RT-PCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.3.1 qPCR
    - 8.3.3.1.1 Overview
- 8.3.4 PCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.4.1 Multiplex PCR
    - 8.3.4.1.1 Overview
- 8.3.5 Multiplex PCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.5.1 Others
    - 8.3.5.1.1 Overview
- 8.3.6 Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 8.4.1 Overview
- 8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
- 8.5.1 Overview
- 8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.6 DNA Microarrays
- 8.6.1 Overview
- 8.6.2 DNA Microarrays: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.7 In-Situ Hybridization (ISH)
- 8.7.1 Overview
- 8.7.2 In-Situ Hybridization (ISH): Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

9.1 Overview
9.2 Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
9.3 Assays and Kits
- 9.3.1 Overview
- 9.3.2 Assays and Kits: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Instruments
- 9.4.1 Overview
- 9.4.2 Instruments: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Services and Software
- 9.5.1 Overview
- 9.5.2 Services and Software: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. Global Molecular Diagnostics Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals and Clinics
- 10.3.1 Overview
- 10.3.2 Hospitals and Clinics: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Diagnostics Laboratories
- 10.4.1 Overview
- 10.4.2 Diagnostics Laboratories: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Research and Academic Institutes
- 10.5.1 Overview
- 10.5.2 Research and Academic Institutes: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. Molecular Diagnostics Market - Geographical Analysis

11.1 North America Molecular Diagnostics Market, Revenue And Forecast To 2030
- 11.1.1 Overview
- 11.1.2 North America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.3 North America Molecular Diagnostics Market, by Disease Area
- 11.1.4 North America Molecular Diagnostics Market, by Technology
  - 11.1.4.1 North America Molecular Diagnostics Market, by Polymerase Chain Reaction (PCR)
- 11.1.5 North America Molecular Diagnostics Market, by Product and Services
- 11.1.6 North America Molecular Diagnostics Market, by End User
  - 11.1.6.1 North America Molecular Diagnostics Market, by Country
- 11.1.7 US
  - 11.1.7.1 Overview
- 11.1.8 US Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.9 US Molecular Diagnostics Market, by Disease Area
- 11.1.10 US Molecular Diagnostics Market, by Technology
  - 11.1.10.1 US Molecular Diagnostics Market, by Polymerase Chain Reaction (PCR)
- 11.1.11 US Molecular Diagnostics Market, by Product and Services
- 11.1.12 US Molecular Diagnostics Market, by End User
- 11.1.13 Canada
  - 11.1.13.1 Overview
- 11.1.14 Canada Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.15 Canada Molecular Diagnostics Market, by Disease Area
- 11.1.16 Canada Molecular Diagnostics Market, by Technology
  - 11.1.16.1 Canada Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.17 Canada Molecular Diagnostics Market, by Product and Services
- 11.1.18 Canada Molecular Diagnostics Market, by End User
- 11.1.19 Mexico
  - 11.1.19.1 Overview
- 11.1.20 Mexico Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.21 Mexico Molecular Diagnostics Market, by Disease Area
- 11.1.22 Mexico Molecular Diagnostics Market, by Technology
  - 11.1.22.1 Mexico Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.23 Mexico Molecular Diagnostics Market, by Product and Services
- 11.1.24 Mexico Molecular Diagnostics Market, by End User
11.2 Europe Molecular Diagnostics Market, Revenue And Forecast to 2030
- 11.2.1 Overview
- 11.2.2 Europe Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.2.3 Europe Molecular Diagnostics Market, by Disease Area
- 11.2.4 Europe Molecular Diagnostics Market, by Technology
  - 11.2.4.1 Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.2.5 Europe Molecular Diagnostics Market, by Product and Services
- 11.2.6 Europe Molecular Diagnostics Market, by End User
  - 11.2.6.1 Europe Molecular Diagnostics Market by Country
- 11.2.7 Germany
  - 11.2.7.1 Overview
- 11.2.8 Germany Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.2.9 Germany Molecular Diagnostics Market, by Disease Area
- 11.2.10 Germany Molecular Diagnostics Market, by Technology
  - 11.2.10.1 Germany Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.2.11 Germany Molecular Diagnostics Market, by Product and Services
- 11.2.12 Germany Molecular Diagnostics Market, by End User
- 11.2.13 UK
  - 11.2.13.1 Overview
- 11.2.14 UK Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.2.15 UK Molecular Diagnostics Market, by Disease Area
- 11.2.16 UK Molecular Diagnostics Market, by Technology
  - 11.2.16.1 UK Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.2.17 UK Molecular Diagnostics Market, by Product and Services
- 11.2.18 UK Molecular Diagnostics Market, by End User
- 11.2.19 France
  - 11.2.19.1 Overview
- 11.2.20 France Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.2.21 France Molecular Diagnostics Market, by Disease Area
- 11.2.22 France Molecular Diagnostics Market, by Technology
  - 11.2.22.1 France Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.2.23 France Molecular Diagnostics Market, by Product and Services
- 11.2.24 France Molecular Diagnostics Market, by End User
- 11.2.25 Italy
  - 11.2.25.1 Overview
- 11.2.26 Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.2.27 Italy Molecular Diagnostics Market, by Disease Area
- 11.2.28 Italy Molecular Diagnostics Market, by Technology
  - 11.2.28.1 Italy Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.2.29 Italy Molecular Diagnostics Market, by Product and Services
- 11.2.30 Italy Molecular Diagnostics Market, by End User
- 11.2.31 Spain
  - 11.2.31.1 Overview
- 11.2.32 Spain Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.2.33 Spain Molecular Diagnostics Market, by Disease Area
- 11.2.34 Spain Molecular Diagnostics Market, by Technology
  - 11.2.34.1 Spain Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    - 11.2.34.1.1 Spain Molecular Diagnostics Market, by Product and Services
- 11.2.35 Spain Molecular Diagnostics Market, by End User
- 11.2.36 Rest of Europe
  - 11.2.36.1 Overview
- 11.2.37 Rest of Europe Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.2.38 Rest of Europe Molecular Diagnostics Market, by Disease Area
- 11.2.39 Rest of Europe Molecular Diagnostics Market, by Technology
  - 11.2.39.1 Rest of Europe Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.2.40 Rest of Europe Molecular Diagnostics Market, by Product and Services
- 11.2.41 Rest of Europe Molecular Diagnostics Market, by End User
11.3 Asia Pacific Molecular Diagnostics Market, Revenue And Forecast to 2030
- 11.3.1 Overview
- 11.3.2 Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.3 Asia Pacific Molecular Diagnostics Market, by Disease Area
- 11.3.4 Asia Pacific Molecular Diagnostics Market, by Technology
  - 11.3.4.1 Asia Pacific Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.3.5 Asia Pacific Molecular Diagnostics Market, by Product and Services
- 11.3.6 Asia Pacific Molecular Diagnostics Market, by End User
  - 11.3.6.1 Asia Pacific Molecular Diagnostics Market by Country
- 11.3.7 China
  - 11.3.7.1 Overview
- 11.3.8 China Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.9 China Molecular Diagnostics Market, by Disease Area
- 11.3.10 China Molecular Diagnostics Market, by Technology
  - 11.3.10.1 China Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.3.11 China Molecular Diagnostics Market, by Product and Services
- 11.3.12 China Molecular Diagnostics Market, by End User
- 11.3.13 Japan
  - 11.3.13.1 Overview
- 11.3.14 Japan Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.15 Japan Molecular Diagnostics Market, by Disease Area
- 11.3.16 Japan Molecular Diagnostics Market, by Technology
  - 11.3.16.1 Japan Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.3.17 Japan Molecular Diagnostics Market, by Product and Services
- 11.3.18 Japan Molecular Diagnostics Market, by End User
- 11.3.19 India
  - 11.3.19.1 Overview
- 11.3.20 India Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.21 India Molecular Diagnostics Market, by Disease Area
- 11.3.22 India Molecular Diagnostics Market, by Technology
  - 11.3.22.1 India Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.3.23 India Molecular Diagnostics Market, by Product and Services
- 11.3.24 India Molecular Diagnostics Market, by End User
- 11.3.25 Australia
  - 11.3.25.1 Overview
- 11.3.26 Australia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.27 Australia Molecular Diagnostics Market, by Disease Area
- 11.3.28 Australia Molecular Diagnostics Market, by Technology
  - 11.3.28.1 Australia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.3.29 Australia Molecular Diagnostics Market, by Product and Services
- 11.3.30 Australia Molecular Diagnostics Market, by End User
- 11.3.31 South Korea
  - 11.3.31.1 Overview
- 11.3.32 South Korea Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.33 South Korea Molecular Diagnostics Market, by Disease Area
- 11.3.34 South Korea Molecular Diagnostics Market, by Technology
  - 11.3.34.1 South Korea Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.3.35 South Korea Molecular Diagnostics Market, by Product and Services
- 11.3.36 South Korea Molecular Diagnostics Market, by End User
- 11.3.37 Singapore
  - 11.3.37.1 Overview
- 11.3.38 Singapore Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.39 Singapore Molecular Diagnostics Market, by Disease Area
- 11.3.40 Singapore Molecular Diagnostics Market, by Technology
  - 11.3.40.1 Singapore Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.3.41 Singapore Molecular Diagnostics Market, by Product and Services
- 11.3.42 Singapore Molecular Diagnostics Market, by End User
- 11.3.43 Malaysia
  - 11.3.43.1 Overview
- 11.3.44 Malaysia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.45 Malaysia Molecular Diagnostics Market, by Disease Area
- 11.3.46 Malaysia Molecular Diagnostics Market, by Technology
  - 11.3.46.1 Malaysia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.3.47 Malaysia Molecular Diagnostics Market, by Product and Services
- 11.3.48 Malaysia Molecular Diagnostics Market, by End User
- 11.3.49 Philippines
  - 11.3.49.1 Overview
- 11.3.50 Philippines Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.51 Philippines Molecular Diagnostics Market, by Disease Area
- 11.3.52 Philippines Molecular Diagnostics Market, by Technology
  - 11.3.52.1 Philippines Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.3.53 Philippines Molecular Diagnostics Market, by Product and Services
- 11.3.54 Philippines Molecular Diagnostics Market, by End User
- 11.3.55 Thailand
  - 11.3.55.1 Overview
- 11.3.56 Thailand Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.57 Thailand Molecular Diagnostics Market, by Disease Area
- 11.3.58 Thailand Molecular Diagnostics Market, by Technology
  - 11.3.58.1 Thailand Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.3.59 Thailand Molecular Diagnostics Market, by Product and Services
- 11.3.60 Thailand Molecular Diagnostics Market, by End User
- 11.3.61 Indonesia
  - 11.3.61.1 Overview
- 11.3.62 Indonesia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.63 Indonesia Molecular Diagnostics Market, by Disease Area
- 11.3.64 Indonesia Molecular Diagnostics Market, by Technology
  - 11.3.64.1 Indonesia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.3.65 Indonesia Molecular Diagnostics Market, by Product and Services
- 11.3.66 Indonesia Molecular Diagnostics Market, by End User
- 11.3.67 Vietnam
  - 11.3.67.1 Overview
- 11.3.68 Vietnam Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.69 Vietnam Molecular Diagnostics Market, by Disease Area
- 11.3.70 Vietnam Molecular Diagnostics Market, by Technology
  - 11.3.70.1 Vietnam Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.3.71 Vietnam Molecular Diagnostics Market, by Product and Services
- 11.3.72 Vietnam Molecular Diagnostics Market, by End User
- 11.3.73 Rest of Asia Pacific
  - 11.3.73.1 Overview
- 11.3.74 Rest of Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.75 Rest of Asia Pacific Molecular Diagnostics Market, by Disease Area
- 11.3.76 Rest of Asia Pacific Molecular Diagnostics Market, by Technology
  - 11.3.76.1 Rest of Asia Pacific Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.3.77 Rest of Asia Pacific Molecular Diagnostics Market, by Product and Services
- 11.3.78 Rest of Asia Pacific Molecular Diagnostics Market, by End User
11.4 Middle East & Africa Molecular Diagnostics Market, Revenue And Forecast to 2030
- 11.4.1 Overview
- 11.4.2 Middle East & Africa Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.4.3 Middle East & Africa Molecular Diagnostics Market, by Disease Area
- 11.4.4 Middle East & Africa Molecular Diagnostics Market, by Technology
  - 11.4.4.1 Middle East & Africa Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.4.5 Middle East & Africa Molecular Diagnostics Market, by Product and Services
- 11.4.6 Middle East & Africa Molecular Diagnostics Market, by End User
  - 11.4.6.1 Middle East & Africa Molecular Diagnostics Market by Country
- 11.4.7 UAE
  - 11.4.7.1 Overview
- 11.4.8 UAE Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.4.9 UAE Molecular Diagnostics Market, by Disease Area
- 11.4.10 UAE Molecular Diagnostics Market, by Technology
  - 11.4.10.1 UAE Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.4.11 UAE Molecular Diagnostics Market, by Product and Services
- 11.4.12 UAE Molecular Diagnostics Market, by End User
- 11.4.13 Saudi Arabia
  - 11.4.13.1 Overview
- 11.4.14 Saudi Arabia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.4.15 Saudi Arabia Molecular Diagnostics Market, by Disease Area
- 11.4.16 Saudi Arabia Molecular Diagnostics Market, by Technology
  - 11.4.16.1 Saudi Arabia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.4.17 Saudi Arabia Molecular Diagnostics Market, by Product and Services
- 11.4.18 Saudi Arabia Molecular Diagnostics Market, by End User
- 11.4.19 South Africa
  - 11.4.19.1 Overview
- 11.4.20 South Africa Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.4.21 South Africa Molecular Diagnostics Market, by Disease Area
- 11.4.22 South Africa Molecular Diagnostics Market, by Technology
  - 11.4.22.1 South Africa Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.4.23 South Africa Molecular Diagnostics Market, by Product and Services
- 11.4.24 South Africa Molecular Diagnostics Market, by End User
- 11.4.25 Rest of Middle East & Africa
  - 11.4.25.1 Overview
- 11.4.26 Rest of Middle East & Africa Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.4.27 Rest of Middle East & Africa Molecular Diagnostics Market, by Disease Area
- 11.4.28 Rest of Middle East & Africa Molecular Diagnostics Market, by Technology
  - 11.4.28.1 Rest of Middle East & Africa Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.4.29 Rest of Middle East & Africa Molecular Diagnostics Market, by Product and Services
- 11.4.30 Rest of Middle East & Africa Molecular Diagnostics Market, by End User
11.5 South & Central America Molecular Diagnostics Market, Revenue And Forecast to 2030
- 11.5.1 Overview
- 11.5.2 South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.5.3 South & Central America Molecular Diagnostics Market, by Disease Area
- 11.5.4 South & Central America Molecular Diagnostics Market, by Technology
  - 11.5.4.1 South & Central America Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.5.5 South & Central America Molecular Diagnostics Market, by Product and Services
- 11.5.6 South & Central America Molecular Diagnostics Market, by End User
  - 11.5.6.1 South & Central America Molecular Diagnostics Market by Country
- 11.5.7 Brazil
  - 11.5.7.1 Overview
- 11.5.8 Brazil Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.5.9 Brazil Molecular Diagnostics Market, by Disease Area
- 11.5.10 Brazil Molecular Diagnostics Market, by Technology
  - 11.5.10.1 Brazil Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.5.11 Brazil Molecular Diagnostics Market, by Product and Services
- 11.5.12 Brazil Molecular Diagnostics Market, by End User
- 11.5.13 Argentina
  - 11.5.13.1 Overview
- 11.5.14 Argentina Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.5.15 Argentina Molecular Diagnostics Market, by Disease Area
- 11.5.16 Argentina Molecular Diagnostics Market, by Technology
  - 11.5.16.1 Argentina Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.5.17 Argentina Molecular Diagnostics Market, by Product and Services
- 11.5.18 Argentina Molecular Diagnostics Market, by End User
- 11.5.19 Rest of South & Central America
  - 11.5.19.1 Overview
- 11.5.20 Rest of South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.5.21 Rest of South & Central America Molecular Diagnostics Market, by Disease Area
- 11.5.22 Rest of South & Central America Molecular Diagnostics Market, by Technology
  - 11.5.22.1 Rest of South & Central America Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.5.23 Rest of South & Central America Molecular Diagnostics Market, by Product and Services
- 11.5.24 Rest of South & Central America Molecular Diagnostics Market, by End User

12. Pre & Post Covid-19 Impact

12.1 Pre & Post Covid-19 Impact

13. Molecular Diagnostics Market Industry Landscape

13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market (%)
13.3 Organic Developments
- 13.3.1 Overview
13.4 Inorganic Developments
- 13.4.1 Overview

14. Molecular Diagnostics Market, Key Company Profiles

14.1 Abbott Laboratories
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Agilent Technologies Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Thermo Fisher Scientific Inc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 F. Hoffmann-La Roche Ltd
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Qiagen NV
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 bioMerieux SA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Illumina Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Danaher
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Siemens Healthineers AG
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Novartis AG
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 TBG Diagnostics Limited
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments

15. Appendix

15.1 About Us
15.2 Glossary of Terms